ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS

We studied effects of estriol (E3), at the doses corresponding to the I and III trimesters of pregnancy,upon expression of functional markers on T-regulatory (Treg) and Th17-producing (Th17) lymphocytes, aswell as the production of relevant cytokines by the cells of patients with multiple sclerosis...

Full description

Bibliographic Details
Main Authors: I. V. Nekrasova, S. V. Shirshev, I. Yu. Danchenko
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/23
_version_ 1826534419722141696
author I. V. Nekrasova
S. V. Shirshev
I. Yu. Danchenko
author_facet I. V. Nekrasova
S. V. Shirshev
I. Yu. Danchenko
author_sort I. V. Nekrasova
collection DOAJ
description We studied effects of estriol (E3), at the doses corresponding to the I and III trimesters of pregnancy,upon expression of functional markers on T-regulatory (Treg) and Th17-producing (Th17) lymphocytes, aswell as the production of relevant cytokines by the cells of patients with multiple sclerosis (MS), as comparedwith healthy donors. It was found that the levels of CD4+FoxP3+CTLA-4+ (Treg) lymphocytes in MS patientswere initially lower than those of healthy donors. Percentages of CD4+RORγt+IL-17A+ (Th17) lymphocytesdid not significantly differ from those in healthy donors, still showing a tendency for increase. Baseline levelsof IL-17 and IL-6 in cell culture supernates of MS patients were higher than in healthy donors, along withreduced contents of the anti-inflammatory IL-10 cytokine. Percentage of Tregs was increased under theinfluence of estriol, whereas Th17 proportion was diminished. These hormonal effects upon lymphocyteswere reproducible both for healthy donors, and MS patients. Moreover, estriol stimulated IL-10 productionand inhibited secretion of IL-6 and IL-17. Therefore, a sufficient release of MS symptoms observed duringpregnancy may be explained by influence of estriol, thus extending opportunities for rational use of this steroidhormone in MS treatment
first_indexed 2024-03-08T05:52:10Z
format Article
id doaj.art-f3f663ba9e7c488fb106971d8a5966d6
institution Directory Open Access Journal
issn 1563-0625
2313-741X
language Russian
last_indexed 2025-03-14T02:22:44Z
publishDate 2014-07-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj.art-f3f663ba9e7c488fb106971d8a5966d62025-03-11T17:58:59ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2014-07-01161536010.15789/1563-0625-2014-1-53-6023ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSISI. V. Nekrasova0S. V. Shirshev1I. Yu. Danchenko2Institute of Ecology and Genetics of Microorganisms, Ural Branch, Russian Academy of Sciences, PermInstitute of Ecology and Genetics of Microorganisms, Ural Branch, Russian Academy of Sciences, PermPerm State Medical Academy, PermWe studied effects of estriol (E3), at the doses corresponding to the I and III trimesters of pregnancy,upon expression of functional markers on T-regulatory (Treg) and Th17-producing (Th17) lymphocytes, aswell as the production of relevant cytokines by the cells of patients with multiple sclerosis (MS), as comparedwith healthy donors. It was found that the levels of CD4+FoxP3+CTLA-4+ (Treg) lymphocytes in MS patientswere initially lower than those of healthy donors. Percentages of CD4+RORγt+IL-17A+ (Th17) lymphocytesdid not significantly differ from those in healthy donors, still showing a tendency for increase. Baseline levelsof IL-17 and IL-6 in cell culture supernates of MS patients were higher than in healthy donors, along withreduced contents of the anti-inflammatory IL-10 cytokine. Percentage of Tregs was increased under theinfluence of estriol, whereas Th17 proportion was diminished. These hormonal effects upon lymphocyteswere reproducible both for healthy donors, and MS patients. Moreover, estriol stimulated IL-10 productionand inhibited secretion of IL-6 and IL-17. Therefore, a sufficient release of MS symptoms observed duringpregnancy may be explained by influence of estriol, thus extending opportunities for rational use of this steroidhormone in MS treatmenthttps://www.mimmun.ru/mimmun/article/view/23multiple sclerosisestriolt regulatory lymphocytesth17 lymphocytescytokines
spellingShingle I. V. Nekrasova
S. V. Shirshev
I. Yu. Danchenko
ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
Медицинская иммунология
multiple sclerosis
estriol
t regulatory lymphocytes
th17 lymphocytes
cytokines
title ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
title_full ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
title_fullStr ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
title_full_unstemmed ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
title_short ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
title_sort estriol in functional modulation of regulatory lymphocytes in multiple sclerosis
topic multiple sclerosis
estriol
t regulatory lymphocytes
th17 lymphocytes
cytokines
url https://www.mimmun.ru/mimmun/article/view/23
work_keys_str_mv AT ivnekrasova estriolinfunctionalmodulationofregulatorylymphocytesinmultiplesclerosis
AT svshirshev estriolinfunctionalmodulationofregulatorylymphocytesinmultiplesclerosis
AT iyudanchenko estriolinfunctionalmodulationofregulatorylymphocytesinmultiplesclerosis